News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
780,470 Results
Type
Article (57996)
Company Profile (544)
Press Release (721901)
Multimedia
Podcasts (165)
Webinars (21)
Section
Business (240296)
Career Advice (2221)
Deals (36501)
Drug Delivery (157)
Drug Development (82120)
Employer Resources (134)
FDA (16982)
Job Trends (16197)
News (355560)
Policy (33809)
Tag
2027 BioCapital Standard (2)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (3)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (5)
2027 Genetown Standard (10)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (8)
Academia (2861)
Academic (1)
Accelerated approval (62)
ADA (50)
Adcomms (23)
Allergies (217)
Alliances (51260)
ALS (258)
Alzheimer's disease (1968)
Antibody-drug conjugate (ADC) (623)
Approvals (17604)
Artificial intelligence (893)
ASCO (328)
Autoimmune disease (422)
Automation (71)
Bankruptcy (361)
Belgium (6)
Best Places to Work (12348)
BIO (76)
Biologics (13)
BIOSECURE Act (19)
Biosimilars (250)
BioSpace Insights (113)
Biotechnology (317)
Bispecific (2)
Bladder cancer (222)
Brain cancer (86)
Breast cancer (888)
Cancer (7007)
Cardiovascular disease (580)
Career advice (1947)
Career pathing (47)
CAR-T (391)
CDC (67)
CDMO (143)
Celiac Disease (4)
Cell therapy (1069)
Cervical cancer (61)
Clinical research (72655)
Collaboration (2567)
Commercialization (11)
Company closure (6)
Compensation (1776)
Complete response letters (100)
COVID-19 (2585)
CRISPR (134)
C-suite (1543)
Cystic fibrosis (172)
Data (9714)
Decentralized trials (2)
Denatured (22)
Depression (205)
Dermatology (127)
Diabetes (724)
Diagnostics (7515)
Digital health (73)
Diversity (8)
Diversity, equity & inclusion (27)
Drug discovery (440)
Drug pricing (205)
Drug shortages (30)
Duchenne muscular dystrophy (338)
Earnings (92622)
Editorial (73)
Employer branding (20)
Employer resources (122)
Events (128718)
Executive appointments (1315)
FDA (21680)
Fibrodysplasia Ossificans Progressiva (11)
Friedreich's ataxia (23)
Frontotemporal dementia (37)
Funding (2124)
Gene editing (273)
Generative AI (73)
Gene therapy (828)
GLP-1 (1105)
Government (4660)
Grass and pollen (8)
Guidances (432)
Healthcare (20510)
Hematology (193)
HIV (107)
Huntington's disease (65)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (125)
Immunology and inflammation (317)
Immuno-oncology (132)
Indications (251)
Infectious disease (2979)
Inflammatory bowel disease (244)
Inflation Reduction Act (14)
Influenza (152)
Intellectual property (358)
Interviews (367)
IPO (17119)
IRA (51)
Job creations (4252)
Job search strategy (1651)
JPM (57)
Kidney cancer (26)
Kidney disease (89)
Labor market (103)
Layoffs (566)
Leadership (45)
Legal (8266)
Licensing (31)
Liver cancer (107)
Longevity (42)
Lung cancer (955)
Lymphoma (508)
Machine learning (72)
Management (51)
Manufacturing (1377)
Marketing (13)
MASH (223)
Medical affairs (3)
Medical device (14754)
Medtech (15020)
Mergers & acquisitions (20887)
Metabolic disorders (1763)
mRNA (252)
Multiple sclerosis (219)
Multispecific (1)
NASH (22)
Netherlands (5)
Neurodegenerative disease (527)
Neuropsychiatric disorders (128)
Neuroscience (3842)
Neurotech (1)
NextGen: Class of 2026 (7376)
Non-profit (5002)
Now hiring (55)
Obesity (780)
Opinion (333)
Ovarian cancer (258)
Pain (316)
Pancreatic cancer (389)
Parkinson's disease (437)
Partnered (35)
Patents (728)
Patient recruitment (949)
Patient selection (7)
Peanut (73)
People (63569)
Peptides (8)
Pharmaceutical (78)
Pharmacy benefit managers (34)
Phase 1 (22662)
Phase 2 (31717)
Phase 3 (23820)
Pipeline (12246)
Policy (344)
Postmarket research (2803)
Preclinical (9994)
Press Release (72)
Prostate cancer (366)
Psychedelics (79)
Radiopharmaceuticals (402)
Rare diseases (1346)
Real estate (6749)
Recruiting (61)
Regenerative medicine (2)
Regulatory (27659)
Reports (50)
Research institute (2664)
Resumes & cover letters (308)
Rett syndrome (52)
RNA editing (24)
RSV (89)
Schizophrenia (200)
Series A (369)
Series B (265)
Service/supplier (13)
Sickle cell disease (129)
Special edition (28)
Spinal muscular atrophy (175)
Sponsored (44)
Startups (3896)
State (2)
Stomach cancer (14)
Substance use disorders (21)
Supply chain (148)
Tariffs (89)
The Weekly (140)
Vaccines (1163)
Venture capital (129)
Weight loss (486)
Women's health (153)
Worklife (18)
Date
Today (124)
Last 7 days (492)
Last 30 days (2556)
Last 365 days (32219)
2026 (23423)
2025 (31624)
2024 (36102)
2023 (40853)
2022 (51773)
2021 (56426)
2020 (55687)
2019 (49674)
2018 (37399)
2017 (32863)
2016 (32873)
2015 (38844)
2014 (33617)
2013 (29538)
2012 (30381)
2011 (30761)
2010 (29946)
Location
Africa (878)
Alabama (110)
Alaska (7)
Arizona (438)
Arkansas (15)
Asia (42812)
Australia (7171)
California (15847)
Canada (4345)
China (1809)
Colorado (677)
Connecticut (708)
Delaware (477)
Europe (96640)
Florida (2430)
Georgia (519)
Hawaii (5)
Idaho (68)
Illinois (1320)
India (126)
Indiana (716)
Iowa (30)
Japan (703)
Kansas (152)
Kentucky (66)
Louisiana (68)
Maine (89)
Maryland (1898)
Massachusetts (11501)
Michigan (431)
Minnesota (870)
Mississippi (7)
Missouri (180)
Montana (37)
Nebraska (31)
Nevada (177)
New Hampshire (91)
New Jersey (4196)
New Mexico (33)
New York (4163)
North Carolina (2055)
North Dakota (12)
Northern California (8051)
Ohio (508)
Oklahoma (30)
Oregon (49)
Pennsylvania (3021)
Puerto Rico (34)
Rhode Island (58)
South America (1201)
South Carolina (96)
South Dakota (1)
Southern California (6322)
Tennessee (265)
Texas (2595)
United States (56230)
Utah (482)
Vermont (2)
Virginia (403)
Washington D.C. (84)
Washington State (1288)
West Virginia (4)
Wisconsin (180)
Wyoming (4)
780,470 Results for "new chemical entities inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia - A New Chemical Entity Opening New Horizons in Psychiatric Innovation
February 22, 2026
·
11 min read
Press Releases
GRAIL Completes $110 Million Equity Financing With Samsung Entities
June 25, 2026
·
9 min read
Press Releases
PureTech Founded Entity Celea Therapeutics to Deliver Two Presentations at the Upcoming European Respiratory Society (ERS) Congress
August 25, 2026
·
8 min read
Press Releases
Lunai Bioworks (Nasdaq: LNAI) Demonstrates AI Chemical-Risk Screening for Generative AI
September 16, 2026
·
8 min read
Press Releases
PureTech Founded Entity Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers
September 9, 2026
·
12 min read
Press Releases
CELLnTEC Launches New Website to Improve Access to Advanced Cell Culture Solutions, Technical Resources, and Application Support
The new digital platform reinforces CELLnTEC’s positioning as the pioneer in chemically defined, animal-free tissue culture and a leader in epithelial and skin tissue engineering.
July 20, 2026
·
1 min read
Press Releases
Loop Chemicals Licenses Chemical Looping Ammonia Technology from Sandia National Laboratories
May 7, 2026
·
3 min read
Press Releases
PureTech Founded Entity Celea Therapeutics Completes $180 Million Financing to Advance Deupirfenidone as a Potential New Standard of Care to Treat Idiopathic Pulmonary Fibrosis (IPF)
July 2, 2026
·
12 min read
Press Releases
American Chemical Society CRT | Model Medicines Publishes Class-Leading, Regulatory Grade Toxicology Model AmesNet™, Validation of GALILEO™ Platform & ChemPrint™ Model Underpinning Drug Pipeline
AmesNet’s Task-Conditioned Learning architecture outperforms FDA, MIT, Tencent, and the University of Sydney models in both sensitivity and balanced accuracy on out-of-domain chemical data on a public dataset; AmesNet is built on top of ChemPrint, the core and proprietary deep-learning engine of the GALILEO platform that powers the company’s drug pipeline.
June 30, 2026
·
1 min read
BioMidwest
Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
Recursion announced it has signed an agreement with Bayer AG to in-license a new chemical entity that emerged from the companies’ fibrosis research collaboration.
January 4, 2024
·
4 min read
1 of 78,047
Next
